Yari Ciribilli

1.7k total citations
54 papers, 1.3k citations indexed

About

Yari Ciribilli is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Yari Ciribilli has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 32 papers in Oncology and 11 papers in Genetics. Recurrent topics in Yari Ciribilli's work include Cancer-related Molecular Pathways (24 papers), RNA modifications and cancer (12 papers) and Epigenetics and DNA Methylation (8 papers). Yari Ciribilli is often cited by papers focused on Cancer-related Molecular Pathways (24 papers), RNA modifications and cancer (12 papers) and Epigenetics and DNA Methylation (8 papers). Yari Ciribilli collaborates with scholars based in Italy, United States and Germany. Yari Ciribilli's co-authors include Alberto Inga, Alessandra Bisio, Federica Alessandrini, Paola Monti, Gilberto Fronza, Jürgen Borlak, Michael A. Resnick, Stella Marie Reamon-Buettner, Paola Menichini and Toma Tebaldi and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Yari Ciribilli

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yari Ciribilli Italy 23 983 521 319 160 131 54 1.3k
Hestia Mellert United States 15 1.8k 1.8× 736 1.4× 352 1.1× 108 0.7× 86 0.7× 31 2.1k
Xiaodong Liao China 12 902 0.9× 442 0.8× 303 0.9× 79 0.5× 174 1.3× 22 1.2k
Trevor G. Shepherd Canada 26 1.1k 1.2× 644 1.2× 406 1.3× 175 1.1× 173 1.3× 64 1.8k
Xiao‐Xin Sun United States 24 1.9k 2.0× 899 1.7× 430 1.3× 107 0.7× 129 1.0× 42 2.2k
Nathalie Meyer‐Schaller Switzerland 17 1.2k 1.2× 494 0.9× 399 1.3× 153 1.0× 128 1.0× 21 1.5k
Jan van Riggelen United States 17 1.3k 1.3× 483 0.9× 333 1.0× 87 0.5× 95 0.7× 20 1.7k
Chit Fang Cheok Singapore 20 1.2k 1.2× 801 1.5× 279 0.9× 78 0.5× 120 0.9× 30 1.6k
Siddhartha Deb Australia 20 660 0.7× 435 0.8× 244 0.8× 76 0.5× 183 1.4× 48 1.3k
Damian J. Junk United States 17 777 0.8× 695 1.3× 341 1.1× 81 0.5× 74 0.6× 27 1.4k
Meena Shrivastav United States 11 1.4k 1.4× 516 1.0× 293 0.9× 64 0.4× 158 1.2× 12 1.7k

Countries citing papers authored by Yari Ciribilli

Since Specialization
Citations

This map shows the geographic impact of Yari Ciribilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yari Ciribilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yari Ciribilli more than expected).

Fields of papers citing papers by Yari Ciribilli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yari Ciribilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yari Ciribilli. The network helps show where Yari Ciribilli may publish in the future.

Co-authorship network of co-authors of Yari Ciribilli

This figure shows the co-authorship network connecting the top 25 collaborators of Yari Ciribilli. A scholar is included among the top collaborators of Yari Ciribilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yari Ciribilli. Yari Ciribilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciribilli, Yari, S. Brugnara, Carlo Mosci, et al.. (2025). Exploring p53 isoforms: unraveling heterogeneous p53 tumor suppressor functionality in uveal melanoma. Cell Death Discovery. 12(1). 39–39.
2.
Ferro, Antonella, Michela Campora, A. Caldara, et al.. (2024). Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine. 13(12). 3611–3611. 8 indexed citations
3.
Forcato, Mattia, Giovanni Bertalot, Mattia Barbareschi, et al.. (2023). ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis. Cell Death and Disease. 14(4). 11 indexed citations
4.
Ciribilli, Yari, et al.. (2022). The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer. International Journal of Molecular Sciences. 23(13). 7213–7213. 6 indexed citations
5.
Forcato, Mattia, et al.. (2021). ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genes. Cell Death and Disease. 12(8). 742–742. 17 indexed citations
6.
Vlašić, Ignacija, et al.. (2021). Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness. Cancers. 13(20). 5231–5231. 19 indexed citations
7.
Ciribilli, Yari, et al.. (2020). MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis. International Journal of Molecular Sciences. 21(20). 7710–7710. 69 indexed citations
8.
Nassiri, Isar, et al.. (2019). Regulatory Crosstalk of Doxorubicin, Estradiol and TNFα Combined Treatment in Breast Cancer-derived Cell Lines. Scientific Reports. 9(1). 2 indexed citations
9.
Ozretić, Petar, Maja Sabol, Vesna Musani, et al.. (2019). Expression profiles of p53/p73, NME and GLI families in metastatic melanoma tissue and cell lines. Scientific Reports. 9(1). 12470–12470. 18 indexed citations
10.
Monti, Paola, Yari Ciribilli, Giorgia Foggetti, et al.. (2019). P63 modulates the expression of theWDFY2gene which is implicated in cancer regulation and limb development. Bioscience Reports. 39(12). 7 indexed citations
11.
Ghisi, Margherita, Sonia Minuzzo, Valentina Agnusdei, et al.. (2018). Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells. Oncogene. 37(28). 3839–3851. 25 indexed citations
12.
Tebaldi, Toma, Sara Zaccara, Federica Alessandrini, et al.. (2015). Whole-genome cartography of p53 response elements ranked on transactivation potential. BMC Genomics. 16(1). 464–464. 52 indexed citations
13.
Lauria, Fabio, Toma Tebaldi, Lorenzo Lunelli, et al.. (2015). RiboAbacus: a model trained on polyribosome images predicts ribosome density and translational efficiency from mammalian transcriptomes. Nucleic Acids Research. 43(22). e153–e153. 7 indexed citations
14.
Leão, Miguel, Clara Pereira, Alessandra Bisio, et al.. (2013). Discovery of a new small-molecule inhibitor of p53–MDM2 interaction using a yeast-based approach. Biochemical Pharmacology. 85(9). 1234–1245. 51 indexed citations
15.
Bisio, Alessandra, Veronica De Sanctis, Valerio Del Vescovo, et al.. (2013). Identification of new p53 target microRNAs by bioinformatics and functional analysis. BMC Cancer. 13(1). 552–552. 50 indexed citations
16.
Monti, Paola, Chiara Perfumo, Alessandra Bisio, et al.. (2011). Dominant-Negative Features of Mutant TP53 in Germline Carriers Have Limited Impact on Cancer Outcomes. Molecular Cancer Research. 9(3). 271–279. 64 indexed citations
17.
Andreotti, Virginia, Yari Ciribilli, Paola Monti, et al.. (2011). p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System. PLoS ONE. 6(6). e20643–e20643. 37 indexed citations
18.
Reamon-Buettner, Stella Marie, Yari Ciribilli, Alberto Inga, & Jürgen Borlak. (2008). A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. Human Molecular Genetics. 17(10). 1397–1405. 75 indexed citations
19.
Monti, Paola, Yari Ciribilli, Jennifer Jordan, et al.. (2007). Transcriptional Functionality of Germ Line p53 Mutants Influences Cancer Phenotype. Clinical Cancer Research. 13(13). 3789–3795. 43 indexed citations
20.
Monti, Paola, Paola Campomenosi, Yari Ciribilli, et al.. (2002). Tumour p53 mutations exhibit promoter selective dominance over wild type p53. Oncogene. 21(11). 1641–1648. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hestia Mellert Breakdown of academic impact, for papers by Xiaodong Liao Breakdown of academic impact, for papers by Trevor G. Shepherd Breakdown of academic impact, for papers by Xiao‐Xin Sun Breakdown of academic impact, for papers by Nathalie Meyer‐Schaller Breakdown of academic impact, for papers by Jan van Riggelen Breakdown of academic impact, for papers by Chit Fang Cheok Breakdown of academic impact, for papers by Siddhartha Deb Breakdown of academic impact, for papers by Damian J. Junk Breakdown of academic impact, for papers by Meena Shrivastav
Rankless by CCL
2026